J.L. Bainbridge & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
J.L. Bainbridge & Co's GILD Position: Q2 2022 in Review
J.L. Bainbridge & Co sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 746 shares — an estimated $44K sold.
J.L. Bainbridge & Co first reported a position in GILD in Q2 2018 and held it in 16 quarters. The position peaked at $22.6M in Q3 2018. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.
- J.L. Bainbridge & Co reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
- J.L. Bainbridge & Co sold 746 Gilead Sciences shares in Q2 2022, an estimated $44K.
- J.L. Bainbridge & Co first reported a position in Gilead Sciences in Q2 2018 and held it in 16 quarters.
- J.L. Bainbridge & Co's Gilead Sciences position peaked at $22.6M in Q3 2018.
- 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.
Based on J.L. Bainbridge & Co's 13F filing for Q2 2022, filed 4 Aug 2022.